Medicare's National Coverage Determination for Aducanumab - A One-Off or a Pragmatic Path Forward?

N Engl J Med. 2022 Oct 27;387(17):1539-1541. doi: 10.1056/NEJMp2210198. Epub 2022 Oct 22.

¹ From the Section of Cardiology, Department of Medicine, University of California, San Francisco, School of Medicine, the Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, and the San Francisco Veterans Affairs Health Care System - all in San Francisco (S.S.D.); and the National Clinician Scholars Program, the Section of General Internal Medicine, and the Yale Collaboration for Research Integrity and Transparency, Department of Internal Medicine, Yale School of Medicine (R.R., J.S.R.), the Department of Health Policy and Management, Yale School of Public Health (J.S.R.), and the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital (J.S.R.) - all in New Haven, CT.

No abstract available

MeSH terms